20579400|t|The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells.
20579400|a|INTRODUCTION: Microtubule-associated protein tau (MAPT) inhibits the function of taxanes and high expression of MAPT decreases the sensitivity to taxanes. The relationship between estrogen receptor (ER) and MAPT in breast cancer is unclear. In this study, we examined the correlation of MAPT expression with the sensitivity of human breast cancer cells to taxanes, and the relationship between ER and MAPT. METHODS: The correlation between MAPT expression and sensitivity to taxanes was investigated in 12 human breast cancer cell lines. Alterations in cellular sensitivity to taxanes were evaluated after knockdown of MAPT expression. ER expression was knocked down or stimulated in MAPT- and ER-positive cell lines to examine the relationship between ER and MAPT. The cells were also treated with hormone drugs (tamoxifen and fulvestrant) and taxanes. RESULTS: mRNA expression of MAPT did not correlate with sensitivity to taxanes. However, expression of MAPT protein isoforms of less than 70 kDa was correlated with a low sensitivity to taxanes. Downregulation of MAPT increased cellular sensitivity to taxanes. MAPT protein expression was increased by stimulation with 17-beta-estradiol or tamoxifen, but decreased by ER downregulation and by fulvestrant, an ER inhibitor. The combination of fulvestrant with taxanes had a synergistic effect, whereas tamoxifen and taxanes had an antagonistic effect. CONCLUSIONS: Expression of MAPT protein isoforms of less than 70 kDa is correlated with a low sensitivity to taxanes in breast cancer cells. ER influences MAPT expression and fulvestrant increases the sensitivity to taxanes in MAPT- and ER-positive breast cancer cells.
20579400	4	21	estrogen receptor	Gene	2099
20579400	33	67	microtubule-associated protein tau	Gene	4137
20579400	69	73	MAPT	Gene	4137
20579400	104	121	estrogen receptor	Gene	2099
20579400	132	143	fulvestrant	Chemical	MESH:D000077267
20579400	158	162	MAPT	Gene	4137
20579400	196	202	taxane	Chemical	MESH:C080625
20579400	206	219	breast cancer	Disease	MESH:D001943
20579400	241	275	Microtubule-associated protein tau	Gene	4137
20579400	277	281	MAPT	Gene	4137
20579400	308	315	taxanes	Chemical	MESH:D043823
20579400	339	343	MAPT	Gene	4137
20579400	373	380	taxanes	Chemical	MESH:D043823
20579400	407	424	estrogen receptor	Gene	2099
20579400	426	428	ER	Gene	2099
20579400	434	438	MAPT	Gene	4137
20579400	442	455	breast cancer	Disease	MESH:D001943
20579400	514	518	MAPT	Gene	4137
20579400	554	559	human	Species	9606
20579400	560	573	breast cancer	Disease	MESH:D001943
20579400	583	590	taxanes	Chemical	MESH:D043823
20579400	621	623	ER	Gene	2099
20579400	628	632	MAPT	Gene	4137
20579400	667	671	MAPT	Gene	4137
20579400	702	709	taxanes	Chemical	MESH:D043823
20579400	733	738	human	Species	9606
20579400	739	752	breast cancer	Disease	MESH:D001943
20579400	804	811	taxanes	Chemical	MESH:D043823
20579400	846	850	MAPT	Gene	4137
20579400	863	865	ER	Gene	2099
20579400	911	915	MAPT	Gene	4137
20579400	921	923	ER	Gene	2099
20579400	980	982	ER	Gene	2099
20579400	987	991	MAPT	Gene	4137
20579400	1041	1050	tamoxifen	Chemical	MESH:D013629
20579400	1055	1066	fulvestrant	Chemical	MESH:D000077267
20579400	1072	1079	taxanes	Chemical	MESH:D043823
20579400	1109	1113	MAPT	Gene	4137
20579400	1152	1159	taxanes	Chemical	MESH:D043823
20579400	1184	1188	MAPT	Gene	4137
20579400	1267	1274	taxanes	Chemical	MESH:D043823
20579400	1294	1298	MAPT	Gene	4137
20579400	1333	1340	taxanes	Chemical	MESH:D043823
20579400	1342	1346	MAPT	Gene	4137
20579400	1400	1417	17-beta-estradiol	Chemical	MESH:D004958
20579400	1421	1430	tamoxifen	Chemical	MESH:D013629
20579400	1449	1451	ER	Gene	2099
20579400	1474	1485	fulvestrant	Chemical	MESH:D000077267
20579400	1490	1492	ER	Gene	2099
20579400	1523	1534	fulvestrant	Chemical	MESH:D000077267
20579400	1540	1547	taxanes	Chemical	MESH:D043823
20579400	1582	1591	tamoxifen	Chemical	MESH:D013629
20579400	1596	1603	taxanes	Chemical	MESH:D043823
20579400	1659	1663	MAPT	Gene	4137
20579400	1741	1748	taxanes	Chemical	MESH:D043823
20579400	1752	1765	breast cancer	Disease	MESH:D001943
20579400	1773	1775	ER	Gene	2099
20579400	1787	1791	MAPT	Gene	4137
20579400	1807	1818	fulvestrant	Chemical	MESH:D000077267
20579400	1848	1855	taxanes	Chemical	MESH:D043823
20579400	1859	1863	MAPT	Gene	4137
20579400	1869	1871	ER	Gene	2099
20579400	1881	1894	breast cancer	Disease	MESH:D001943
20579400	Positive_Correlation	MESH:D004958	4137
20579400	Negative_Correlation	MESH:C080625	MESH:D001943
20579400	Positive_Correlation	MESH:C080625	MESH:D000077267
20579400	Negative_Correlation	MESH:D013629	MESH:D043823
20579400	Negative_Correlation	MESH:D000077267	MESH:D001943
20579400	Negative_Correlation	MESH:D043823	4137
20579400	Association	MESH:D001943	4137
20579400	Positive_Correlation	MESH:D013629	4137
20579400	Negative_Correlation	MESH:D000077267	4137
20579400	Association	2099	4137
20579400	Association	MESH:D001943	2099
20579400	Negative_Correlation	MESH:D000077267	MESH:D043823
20579400	Negative_Correlation	MESH:D043823	MESH:D001943
20579400	Negative_Correlation	MESH:D000077267	2099

